226 related articles for article (PubMed ID: 12782969)
1. Cytochrome P450 2D6 polymorphism and character traits.
Suzuki E; Kitao Y; Ono Y; Iijima Y; Inada T
Psychiatr Genet; 2003 Jun; 13(2):111-3. PubMed ID: 12782969
[TBL] [Abstract][Full Text] [Related]
2. No association between monoamine oxidase A promoter polymorphism and personality traits in Japanese females.
Hakamata Y; Takahashi N; Ishihara R; Saito S; Ozaki N; Honjo S; Ono Y; Inada T
Neurosci Lett; 2005 Dec; 389(3):121-3. PubMed ID: 16139427
[TBL] [Abstract][Full Text] [Related]
3. Association study between the -1021C/T polymorphism of the dopamine-beta-hydroxylase gene promoter and personality traits in healthy subjects.
Kamata M; Suzuki A; Matsumoto Y; Shibuya N; Togashi H; Goto K; Otani K
Neurosci Lett; 2009 Oct; 462(1):54-7. PubMed ID: 19560519
[TBL] [Abstract][Full Text] [Related]
4. Association between monoamine oxidase A (MAOA) and personality traits in Japanese individuals.
Tsuchimine S; Yasui-Furukori N; Kaneda A; Saito M; Nakagami T; Sato K; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1932-5. PubMed ID: 18845200
[TBL] [Abstract][Full Text] [Related]
5. The -67 A/T promoter polymorphism in the dopamine transporter gene affects personality traits of Japanese healthy females.
Shibuya N; Kamata M; Suzuki A; Matsumoto Y; Goto K; Otani K
Behav Brain Res; 2009 Oct; 203(1):23-6. PubMed ID: 19376159
[TBL] [Abstract][Full Text] [Related]
6. Effect of the cytochrome P450 19 (aromatase) gene polymorphism on personality traits in healthy subjects.
Matsumoto Y; Suzuki A; Shibuya N; Sadahiro R; Kamata M; Goto K; Otani K
Behav Brain Res; 2009 Dec; 205(1):234-7. PubMed ID: 19573564
[TBL] [Abstract][Full Text] [Related]
7. Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate.
McConnachie L; Bodor M; Kowdley K; Levy A; Tung B; Thummel K; Phillips B; Bajpai M; Chi V; Esmay JD; Shen DD; Ho RJ
Clin Pharmacol Ther; 2004 Apr; 75(4):282-97. PubMed ID: 15060507
[TBL] [Abstract][Full Text] [Related]
8. The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry.
Chen S; Chou WH; Blouin RA; Mao Z; Humphries LL; Meek QC; Neill JR; Martin WL; Hays LR; Wedlund PJ
Clin Pharmacol Ther; 1996 Nov; 60(5):522-34. PubMed ID: 8941025
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.
Ingelman-Sundberg M
Pharmacogenomics J; 2005; 5(1):6-13. PubMed ID: 15492763
[TBL] [Abstract][Full Text] [Related]
10. A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women.
Melke J; Westberg L; Nilsson S; Landen M; Soderstrom H; Baghaei F; Rosmond R; Holm G; Björntorp P; Nilsson LG; Adolfsson R; Eriksson E
Arch Gen Psychiatry; 2003 Oct; 60(10):1017-23. PubMed ID: 14557147
[TBL] [Abstract][Full Text] [Related]
11. Relation between CYP2D6 genotype, personality, neurocognition and overall psychopathology in healthy volunteers.
Peñas-LLedó EM; Dorado P; Pacheco R; González I; LLerena A
Pharmacogenomics; 2009 Jul; 10(7):1111-20. PubMed ID: 19604084
[TBL] [Abstract][Full Text] [Related]
12. A possible association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and the personality trait of harm avoidance in Japanese healthy subjects.
Hashimoto R; Noguchi H; Hori H; Ohi K; Yasuda Y; Takeda M; Kunugi H
Neurosci Lett; 2007 Nov; 428(1):17-20. PubMed ID: 17945417
[TBL] [Abstract][Full Text] [Related]
13. Association study between a functional polymorphism of tyrosine hydroxylase gene promoter and personality traits in healthy subjects.
Sadahiro R; Suzuki A; Shibuya N; Kamata M; Matsumoto Y; Goto K; Otani K
Behav Brain Res; 2010 Mar; 208(1):209-12. PubMed ID: 19958792
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of CYP2D6 in Chinese mainland.
Ji L; Pan S; Wu J; Marti-Jaun J; Hersberger M
Chin Med J (Engl); 2002 Dec; 115(12):1780-4. PubMed ID: 12622923
[TBL] [Abstract][Full Text] [Related]
15. Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles.
Bogni A; Monshouwer M; Moscone A; Hidestrand M; Ingelman-Sundberg M; Hartung T; Coecke S
Toxicol In Vitro; 2005 Aug; 19(5):621-9. PubMed ID: 15893449
[TBL] [Abstract][Full Text] [Related]
16. CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits.
Dorado P; Peñas-Lledó EM; Llerena A
Pharmacogenomics; 2007 Nov; 8(11):1597-608. PubMed ID: 18034624
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of CYP2D6 influences susceptibility to papillary thyroid cancer.
Lemos MC; Carrilho F; Rodrigues F; Coutinho E; Gomes L; Carvalheiro M; Regateiro FJ
Clin Endocrinol (Oxf); 2007 Aug; 67(2):180-3. PubMed ID: 17547692
[TBL] [Abstract][Full Text] [Related]
18. No association between the TPH A218C polymorphism and personality traits in Japanese healthy subjects.
Suzuki A; Fukasawa T; Shiraishi H; Ishii G; Oshino S; Aoshima T; Otani K
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):395-8. PubMed ID: 17116352
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genes.
Alvarez S; Mas S; Gassó P; Bernardo M; Parellada E; Lafuente A
Fundam Clin Pharmacol; 2010 Dec; 24(6):741-7. PubMed ID: 20041956
[TBL] [Abstract][Full Text] [Related]
20. Association between cytochrome P450 2D6 genotype and harm avoidance.
Roberts RL; Luty SE; Mulder RT; Joyce PR; Kennedy MA
Am J Med Genet B Neuropsychiatr Genet; 2004 May; 127B(1):90-3. PubMed ID: 15108188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
